Doxycycline hyclate - CollaGenex

Drug Profile

Doxycycline hyclate - CollaGenex

Alternative Names: Dermostat; Periostat; Periostat-MR; Periostat-SR

Latest Information Update: 24 Sep 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator State University of New York
  • Class Antibacterials; Collagenases; Skin disorder therapies; Tetracyclines
  • Mechanism of Action Collagenase inhibitors; Metalloprotease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Periodontal disorders
  • Discontinued Acne; Acute coronary syndromes; Dermatitis; Ocular inflammation; Rosacea

Most Recent Events

  • 22 Sep 2010 Taro Pharmaceutical Industries has been acquired by Sun Pharmaceutical Industries
  • 20 Apr 2010 Discontinued - Clinical-Phase-Unknown for Acute coronary syndromes in USA (PO)
  • 20 Apr 2010 Discontinued - Clinical-Phase-Unknown for Dermatitis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top